XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance (in shares) at Sep. 30, 2020   41,780,000        
Beginning Balance at Sep. 30, 2020 $ 132,243 $ 42 $ 146,518   $ (13,994) $ (323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   260,000        
Exercise of stock options 1,958   1,958      
Settlement of restricted stock units (in shares)   935,000        
Settlement of restricted stock units   $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   77,000        
Issuance of common stock under employee stock purchase plan 792   792      
Stock-based compensation expense 5,715   5,715      
Sale of convertible senior notes warrants 23,909   23,909      
Net income 3,186       3,186  
Components of comprehensive income (loss):            
Currency translation adjustment 112         112
Change in unrealized gain (loss) on investments (186)         (186)
Ending Balance (in shares) at Mar. 31, 2021   43,052,000        
Ending Balance at Mar. 31, 2021 167,729 $ 43 178,891   (10,808) (397)
Beginning Balance (in shares) at Dec. 31, 2020   42,668,000        
Beginning Balance at Dec. 31, 2020 141,753 $ 43 151,153   (11,827) 2,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   18,000        
Exercise of stock options 69   69      
Settlement of restricted stock units (in shares)   289,000        
Settlement of restricted stock units (1)   (1)      
Issuance of common stock under employee stock purchase plan (in shares)   77,000        
Issuance of common stock under employee stock purchase plan 793   793      
Stock-based compensation expense 2,968   2,968      
Sale of convertible senior notes warrants 23,909   23,909      
Net income 1,019       1,019  
Components of comprehensive income (loss):            
Currency translation adjustment (2,648)         (2,648)
Change in unrealized gain (loss) on investments (133)         (133)
Ending Balance (in shares) at Mar. 31, 2021   43,052,000        
Ending Balance at Mar. 31, 2021 $ 167,729 $ 43 178,891   (10,808) (397)
Beginning Balance (in shares) at Sep. 30, 2021 44,168,745 44,169,000   (8,000)    
Beginning Balance at Sep. 30, 2021 $ 192,830 $ 44 199,935 $ (140) (6,066) (943)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares) 25,625 25,000        
Exercise of stock options $ 206   206      
Settlement of restricted stock units (in shares)   973,000        
Settlement of restricted stock units   $ 1 (1)      
Issuance of common stock under employee stock purchase plan (in shares)   71,000        
Issuance of common stock under employee stock purchase plan 923   923      
Stock-based compensation expense 6,429   6,429      
Repurchases and retirement of common stock (in shares)   (894,000)   8,000    
Repurchases and retirement of common stock (14,828) $ (1) (1) $ 140 (14,966)  
Net income 4,137       4,137  
Components of comprehensive income (loss):            
Currency translation adjustment (3,129)         (3,129)
Change in unrealized gain (loss) on investments $ (1,098)         (1,098)
Ending Balance (in shares) at Mar. 31, 2022 44,344,361 44,344,000   0    
Ending Balance at Mar. 31, 2022 $ 185,470 $ 44 207,491 $ 0 (16,895) (5,170)
Beginning Balance (in shares) at Dec. 31, 2021   44,297,000        
Beginning Balance at Dec. 31, 2021 187,429 $ 44 203,091   (13,226) (2,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Exercise of stock options (in shares)   16,000        
Exercise of stock options 179   179      
Settlement of restricted stock units (in shares)   248,000        
Issuance of common stock under employee stock purchase plan (in shares)   71,000        
Issuance of common stock under employee stock purchase plan 923   923      
Stock-based compensation expense 3,298   3,298      
Repurchases and retirement of common stock (in shares)   (288,000)        
Repurchases and retirement of common stock (4,682)       (4,682)  
Net income 1,013       1,013  
Components of comprehensive income (loss):            
Currency translation adjustment (1,862)         (1,862)
Change in unrealized gain (loss) on investments $ (828)         (828)
Ending Balance (in shares) at Mar. 31, 2022 44,344,361 44,344,000   0    
Ending Balance at Mar. 31, 2022 $ 185,470 $ 44 $ 207,491 $ 0 $ (16,895) $ (5,170)